Lord Abbett Health Care Fund Class A (LHCAX)

Fund Assets	8.56M
Expense Ratio	1.03%
Min. Investment	$1,500
Turnover	91.00%
Dividend (ttm)	0.03
Dividend Yield	0.13%
Dividend Growth	-44.54%
Payout Frequency	n/a
Ex-Dividend Date	Dec 2, 2025

Previous Close	24.80
YTD Return	9.77%
1-Year Return	27.10%
5-Year Return	23.12%
52-Week Low	19.22
52-Week High	25.01
Beta (5Y)	0.71
Holdings	57
Inception Date	Jul 31, 2019

About LHCAX

Lord Abbett Health Care Fund Class A is an actively managed mutual fund focused on achieving long-term capital appreciation by investing primarily in companies within the health care sector. The fund allocates at least 80% of its net assets to equity and equity-related securities of health care-related firms, making it a targeted vehicle for gaining exposure to the diverse and evolving health care industry. Its portfolio typically includes leading pharmaceutical, biotechnology, and medical device companies, with notable holdings in firms such as Eli Lilly, Novo Nordisk, and Intuitive Surgical. This fund is designed to participate in the growth dynamics of the global health care sector, addressing areas such as drug development, diagnostic tools, and advanced medical technologies. It is categorized as a mid-growth fund and holds a diversified mix of about 58 companies, with approximately 39.5% of assets in its top ten positions. While the fund offers access to a sector with significant long-term growth potential driven by innovation and demographics, it features a front-end sales charge and a relatively high expense ratio compared to its peers. Lord Abbett Health Care Fund Class A plays a specialized role for investors seeking sector-specific exposure within the broader equity markets.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: LHCAX
• Share Class: Class A
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCAX had a total return of 27.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.37%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCVX	Class R6	0.68%
LHCIX	Class I	0.78%
LHCFX	Class F	0.78%

Top 10 Holdings

43.78% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.93%
UnitedHealth Group Incorporated	UNH	4.48%
AstraZeneca PLC	AZN	4.46%
Guardant Health, Inc.	GH	4.34%
Natera, Inc.	NTRA	3.67%
Gilead Sciences, Inc.	GILD	3.45%
Johnson & Johnson	JNJ	3.37%
CVS Health Corporation	CVS	3.33%
Novartis AG	NOVN	3.01%
Galderma Group AG	GALD	2.74%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$0.0335	Dec 2, 2025
Nov 26, 2024	$0.0604	Nov 26, 2024
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3119	Nov 24, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 28, 2026

Data Sources Report a data error